Email Facebook Twitter

Tech company Mporium delivers an outstanding set of Q1 results says CEO De Groot
IronRidge Resources CEO hails spectacular lithium project and money making potential for gold

Glaxosmithkline Fundamentals

Fundamental Data for Glaxosmithkline (GSK)

Share Price: 1,524.40Bid: 1,525.40Ask: 1,525.80Change: 0.00 (0.00%)No Movement on Glaxosmithkline
Spread: 0.40Spread as %: 0.03%Open: 1,526.80High: 0.00Low: 0.00Yesterday’s Close: 1,524.40

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

Glaxosmithkline Market Data

Ticker Code GSK.L
ISIN GB0009252882
Currency GBX
Issue Country GB
Sector Ticker NMX4570
Year End 31-Dec-19
Shares in Issue 4,988m
Market Cap. £77,308m
Market Size 1,500
PE Ratio 20.68
Earnings 73.70p
Dividend 80.00p
Yield 5.25%
# of Trades 0
Vol Sold 0
Vol Bought 0
52 Week High 1,648.80p
52 Week High Date 03-Dec-18
52 Week Low 1,395.80p
52 Week Low Date 25-Apr-18

GSK Fundamentals - IFRS

 £ Millions£ Millions£ Millions£ Millions£ Millions
Income Statement31 Dec '1531 Dec '1431 Dec '1331 Dec '1231 Dec '11
Operating Profit / Loss10,322.003,597.007,028.007,300.007,807.00
Net Interest(653.00)(659.00)(706.00)(729.00)(709.00)
Pre tax Profit10,526.002,968.006,647.006,600.007,698.00
Post tax Profit8,372.002,831.005,628.004,678.005,458.00
Profit for the Period8,372.002,831.005,628.004,678.005,458.00
Equity Holders of Parent Company8,422.002,756.005,436.004,499.005,261.00
Minority Interests(50.00)75.00192.00179.00197.00
Continuing EPS
Earnings per Share (Basic)174.30p57.30p112.50p91.60p104.60p
Earnings per Share (Diluted)172.30p56.70p110.50p90.20p103.20p
Earnings per Share (Adjusted)75.70p95.40p108.40p111.40p114.10p
Continuing and Discontinued EPS
Earnings per Share (Basic)174.30p57.30p112.50p91.60p104.60p
Earnings per Share (Diluted)172.30p56.70p110.50p90.20p103.20p
Earnings per Share (Adjusted)75.70p95.40p108.40p111.40p114.10p
Dividend per Share100.00p80.00p78.00p74.00p75.00p
 £ Millions£ Millions£ Millions£ Millions£ Millions
Balance Sheet31 Dec '1531 Dec '1431 Dec '1331 Dec '1231 Dec '11
Non-Current Assets     
Intangible Assets21,834.0012,044.0013,488.0014,520.0011,556.00
Property, Plant and Equipment9,668.009,052.008,872.008,776.008,748.00
Investment Properties1,255.001,114.00n/an/an/a
Other Financial Assetsn/an/a1.0054.0085.00
Other Non-Current Assets3,895.003,423.002,973.003,073.003,374.00
Current Assets     
Trade and Other Receivables5,615.004,600.005,571.005,242.005,576.00
Cash at Bank and in Hand5,830.004,338.005,534.004,184.005,714.00
Current Asset Investments75.0069.0066.0081.00184.00
Other Current Assets351.001,440.00156.00216.00820.00
Other Assetsn/an/an/an/an/a
Total Assets53,446.0040,651.0042,086.0041,481.0041,080.00
Current Liabilities     
Other Current Liabilities12,109.0010,352.0010,888.0010,184.0012,312.00
Net Current Assetsn/an/an/an/an/a
Non-Current Liabilities     
Other Non-Current Liabilities15,407.006,034.003,896.004,555.003,719.00
Net Assets8,878.004,936.007,812.006,737.008,827.00
Capital and Reserves     
Share Capital1,340.001,339.001,336.001,349.001,387.00
Share Premium Account2,831.002,759.002,595.002,022.001,673.00
Other Reserves2,340.002,239.002,153.001,787.001,602.00
Retained Earnings(1,397.00)(2,074.00)913.00642.003,370.00
Shareholders Funds5,114.004,263.006,997.005,800.008,032.00
Minority Interests / Other Equity3,764.00673.00815.00937.00795.00
Total Equity8,878.004,936.007,812.006,737.008,827.00
 31 Dec '1531 Dec '1431 Dec '1331 Dec '1231 Dec '11
Operating Margin43.15%15.64%27.58%27.62%30.64%
Return on Capital Employed272.92%29.68%53.23%59.97%62.31%
Dividend Cover0.951.191.391.511.63
Dividend Yield5.80%5.80%4.80%5.50%4.80%
PE Ratio18.1014.4014.9012.0012.90
Dividend per Share Growthn/a2.56%5.41%5.71%7.69%
Net Asset Value per Share(266.00p)(147.84p)(117.49p)(158.45p)(54.28p)

Glaxosmithkline Key Personnel

CEOEmma Walmsley
ChairmanMoncef Slaoui
CFOIain Mackay

Share Price, Share Chat, Stock Market news at
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at

Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.